Researchers from MIT and Massachusetts General Hospital have developed a predictive model that...
- Abbott and Novo Nordisk to offer integrated solution for diabetes
- The critical moment: can machine learning save lives in sepsis care?
- National Heart Month: blood pressure monitors are changing diabetes care
- Empatica and DRIVe to work on smartwatch to predict lung infections
- BGU develops new AI platform to track neurodegenerative disorders
Abbott and Novo Nordisk to offer integrated solution for diabetes
Abbott and Novo Nordisk have partnered to bring an integrated digital solution that will involve the sharing of insulin data to facilitate the better management of diabetes.
The critical moment: can machine learning save lives in sepsis care?
Researchers from MIT and Massachusetts General Hospital have developed a predictive model that could guide clinicians in deciding when to give potentially life-saving drugs to patients being treated for sepsis. First author of the study Varesh Prasad explains how the technology works.
National Heart Month: blood pressure monitors are changing diabetes care
Hypertension, also known as high blood pressure, increases a patient’s chances of developing a potentially life-threatening condition such as a heart attack. As diabetes and high blood pressure are closely linked, equipment manufacturer Omron believes blood pressure monitoring is key for diabetic patients. On National Heart Month, Omron Healthcare UK general manager Charlie Fox discusses the company’s latest blood pressuring monitoring technology.
Empatica and DRIVe to work on smartwatch to predict lung infections
Empatica, a Massachusetts Institute of Technology (MIT) Media Lab spin-off, has collaborated with the US BARDA Division of Research, Innovation and Ventures (DRIVe) to develop a new smartwatch to predict lung infections.
BGU develops new AI platform to track neurodegenerative disorders
BGN Technologies, the technology transfer company of Israel-based Ben-Gurion University (BGU), has unveiled a new artificial intelligence (AI) platform to monitor and predict the progression of neurodegenerative diseases.
Medtronic-funded study provides OIRD risk prediction tool
Medtronic has reported preliminary results from the Microstream Capnography Study that provided an easy-to-use risk prediction tool for opioid-induced respiratory depression (OIRD).
Disposable sensors to monitor respiration-related disorders
A University of California, Irvine (UCI) research team has created a wearable, disposable monitor that could continuously track breath rate and volume.
LifeScan reports long-term data for OneTouch Select Plus
LifeScan has reported long-term results for its OneTouch Select Plus blood glucose monitoring platform evaluated over three years in multiple studies involving diabetes patients.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.